CMS seeks to reverse prior stacking guidance and proposes novel transparency requirements for "High-Cost Drugs"
On May 23, 2023, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that addresses a variety of important drug pricing…
District Of Columbia United States Medicaid Services Investment Human Services Medicaid Drug Rebate Program Us Centers For Medicare Medicaid Services
Source: lexology.com